Related Experiment Video
Updated: Aug 9, 2026

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication
W A Bresnahan1, I Boldogh, P Chi
1Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston 77550, USA.
Abstract:
Human cytomegalovirus is a herpesvirus that induces numerous cellular processes upon infection. Among these are activation of cyclin-dependent kinase 2, which regulates cell cycle progression in G1 and S phase. We report here that inhibition of cellular Cdk2 activity blocks HCMV replication. Inhibition of Cdk2 activity by roscovitine inhibits HCMV DNA synthesis, production of infectious progeny, and late antigen expression in infected cells in a dose-dependent manner. HCMV replication is also inhibited by the expression of a Cdk2 dominant negative mutant, whereas expression of wild-type Cdk2 has no effect on viral replication. These data indicate that activation of cellular Cdk2 is necessary for HCMV replication.
Insights
Human cytomegalovirus (HCMV) requires cellular cyclin-dependent kinase 2 (Cdk2) for replication. Inhibiting Cdk2 activity blocks HCMV DNA synthesis, progeny production, and viral antigen expression, indicating Cdk2 is essential for the virus.
Area of Science:
- Virology
- Molecular Biology
- Cell Biology
Background:
- Human cytomegalovirus (HCMV) is a ubiquitous herpesvirus that manipulates host cellular processes.
- Cellular cyclin-dependent kinase 2 (Cdk2) plays a crucial role in regulating the cell cycle at the G1 and S phases.
Purpose of the Study:
- To investigate the necessity of cellular Cdk2 activity for HCMV replication.
- To determine if inhibiting Cdk2 impacts HCMV infection outcomes.
Main Methods:
- Inhibition of Cdk2 activity using the specific inhibitor roscovitine.
- Expression of a dominant-negative Cdk2 mutant in infected cells.
- Assessment of HCMV DNA synthesis, infectious progeny production, and late antigen expression.
Main Results:
- Roscovitine treatment inhibited HCMV DNA synthesis, progeny production, and late antigen expression in a dose-dependent manner.
- Expression of a dominant-negative Cdk2 mutant significantly blocked HCMV replication.
- Expression of wild-type Cdk2 did not affect viral replication.
Conclusions:
- Cellular Cdk2 activation is a necessary event for successful HCMV replication.
- Targeting Cdk2 activity represents a potential antiviral strategy against HCMV infections.
More Related Videos
Related Concept Videos
Positive Regulator Molecules
Inhibition of Cdk Activity
Inhibition of CDK Activity
Cytomegalovirus Disease
Antiviral Nucleoside Inhibitors
Inhibitors of Virion Maturation and Assembly

